Transpact Enterprises Ltd.

View in App
361.00 ▼0%

19 April 2024, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Industry Icon Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.transpact.in
Market Cap 13.96 Cr.
Enterprise Value(EV) 13.99 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.70 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 56.18 Trailing Twelve Months Ending 2023-03
Book Value / Share 13.79 Trailing Twelve Months Ending 2023-03
Price to Book Value 26.18 Calculated using Price: 361.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.04 Cr. 386,730 Shares
FaceValue 10
About Transpact Enterprises Ltd.
Transpact Enterprises, Maharashtra based is a biotechnology startup. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products. Transpact Enterprises mainly designs, develops and distributes Vestibulator, a therapeutic device. The device has been invented by the Society for Innovation and Entrepreneurship, lIT Bombay. And, Transpact Enterprises holds a license to carry out the commercial activities of Vestibulator. It is a co-patented technology of the company and IRCC-IIT Bombay. The company outsources the manufacturing of the device along with the design details to a 3rd party. With the help of advanced software, the company also offers customized device solutions for patients.

Transpact Enterprises Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Transpact Enterprises Ltd. Performance

View details >>
1 Day
1 Week
-9.75%
1 Month
-12.99%
3 Month
-25.38%
6 Month
+14.22%
1 Year
+63.55%
2 Year
+143.43%
5 Year
10 Year

Transpact Enterprises Ltd. Fundamental Ratios

View details >>
7 years 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -27.59 -77.28 -804.02 -97.83 -7.53 -31.12 -11.64
Return on Capital Employed (%) -19.45 -27.62 -66.2 -53.57 -5.23 -21.88 -7.88
Return on Assets (%) -19.19 -25.93 -60.34 -47.48 -4.78 -17.8 -6.14

Transpact Enterprises Ltd. Balance Sheet

View details >>
Particulars 8 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 0 0 0 1 1 1 1 0
Non Curr. Liab. 0 0 0 0 0 0
Curr. Liab. 0 0 0 0 1 0 0 0
Minority Int.
Equity & Liab. 0 0 1 1 1 1 1 1
Non Curr. Assets 0 0 0 1 1 1 1 0
Curr. Assets 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 1 1 1 1 1 1

Transpact Enterprises Ltd. Profit and Loss

View details >>
Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 0 0 0 0
Other Income 0 0 0
Total Income 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0
Interest
Depreciation 0 0 0 0 0
Taxation 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0
Adjusted EPS -2 -3 -11 -11 -2 -6 -2

Transpact Enterprises Ltd. Cash Flow

View details >>
Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -1 0 -1 0
Cash Fr. Inv. 0 0 0
Cash Fr. Finan. 0 0 0 1 0 0 0
Net Change 0 0 0 -1 0
Cash & Cash Eqvt 0 0 0 0 0 -1 0

Transpact Enterprises Ltd. Shareholding Pattern

View details >>
9 Qtrs 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%) 2023-03 (%) 2023-09 (%) 2024-03 (%)
Promoter 45.89 45.89 45.89 45.89 45.89 45.89 32.63 0.13 18.23
Public 54.11 54.11 54.11 54.11 54.11 54.11 67.37 99.87 81.77
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Transpact Enterprises Ltd. Announcements

View details >>
Fri, 19 Apr 2024
Statement Of Deviation & Variation As Per Reg 32 (1)
Compliance under Reg 32(1) for quarter ended March 31 2024
Tue, 16 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
Mon, 15 Apr 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizers report for the Extra-ordinary General meeting held on April 12 2024 at 11.00 A.M.

Transpact Enterprises Ltd. Technical Scans

View details >>
Fri, 19 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at High Opening at High
Opening at Low Opening at Low

Transpact Enterprises Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,001.33 1,484.65 -3.6%
Cipla Ltd. 108,812.62 1,346.70 -0.6%
Divi's Laboratories Ltd. 100,075.02 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. 99,325.26 5,952.10 -1.1%
Zydus Lifesciences Ltd. 96,553.18 959.45 0.0%
Mankind Pharma Ltd. 95,896.87 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. 89,224.37 2,637.40 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 39.97 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.34 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 72.36 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.47 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.52 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.72 2,637.40 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.71 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.20 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.68 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.79 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.48 2,637.40 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,637.40 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,637.40 +1.8%

Transpact Enterprises Ltd. FAQ's

What is Transpact Enterprise share price?
Can I buy Transpact Enterprise shares now?
What is the Market Cap of Transpact Enterprise?
What are the key metrics to analyse Transpact Enterprise?
What is the 52 Week High and Low of Transpact Enterprise?